Baidu
map

脂肪性肝病诊疗规范化的专家建议(2019 年修订版)

2019-11-01 中国研究型医院学会 临床肝胆病杂志.2019,35(11):2426-2430.

目前,非酒精性脂肪性肝病(NAFLD)已成为我国最常见的慢性肝病。本建议从以下5 个方面对NAFLD 的规范化诊断和治疗进行了修订:(1)诊治中心/ 专病门诊的组织架构及功能;(2)筛查和评估:包括筛查对象、初步评估、病因筛查、非酒精性脂肪性肝炎和进展性肝纤维化的无创诊断、肝活组织病理学检查以及代谢紊乱和心血管风险评估等;(3)临床处理包括生活方式(饮食运动减重)调整,合并糖脂代谢紊乱、高血压等特

中文标题:

脂肪性肝病诊疗规范化的专家建议(2019 年修订版)

发布机构:

中国研究型医院学会

发布日期:

2019-11-01

简要介绍:

目前,非酒精性脂肪性肝病(NAFLD)已成为我国最常见的慢性肝病。本建议从以下5 个方面对NAFLD 的规范化诊断和治疗进行了修订:(1)诊治中心/ 专病门诊的组织架构及功能;(2)筛查和评估:包括筛查对象、初步评估、病因筛查、非酒精性脂肪性肝炎和进展性肝纤维化的无创诊断、肝活组织病理学检查以及代谢紊乱和心血管风险评估等;(3)临床处理包括生活方式(饮食运动减重)调整,合并糖脂代谢紊乱、高血压等特殊人群的处理以及脂肪性肝炎和肝纤维化的药物选择;(4)特殊人群的管理包括儿童、妊娠和哺乳期妇女、合并酒精性肝病、慢性HBV 和(或)HCV 感染以及合并自身免疫现象等;(5)监测与随访。本建议旨在优化NAFLD 患者的管理流程,指导临床医生制订更为合理的诊疗决策。

 

拓展指南:脂肪肝相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=脂肪性肝病诊疗规范化的专家建议(2019 年修订版))] GetToolGuiderByIdResponse(projectId=1, id=90c371c00182a659, title=脂肪性肝病诊疗规范化的专家建议(2019 年修订版), enTitle=, guiderFrom=临床肝胆病杂志.2019,35(11):2426-2430., authorId=null, author=, summary=目前,非酒精性脂肪性肝病(NAFLD)已成为我国最常见的慢性肝病。本建议从以下5 个方面对NAFLD 的规范化诊断和治疗进行了修订:(1)诊治中心/ 专病门诊的组织架构及功能;(2)筛查和评估:包括筛查对象、初步评估、病因筛查、非酒精性脂肪性肝炎和进展性肝纤维化的无创诊断、肝活组织病理学检查以及代谢紊乱和心血管风险评估等;(3)临床处理包括生活方式(饮食运动减重)调整,合并糖脂代谢紊乱、高血压等特, cover=, journalId=null, articlesId=null, associationId=1023, associationName=中国研究型医院学会, associationIntro=中国研究型医院学会,英文名称Chinese Research Hospital Association(CRHA),是经国家民政部正式批复并登记注册的全国性一级学会,是独立的法人社团。中国研究型医院学会是由以探索和建设研究型医院为目标的具有医疗服务、科学研究和临床教学&ldquo;三位一体&rdquo;功能的医疗机构,以及从事研究型医院理论与实践研究的人员自愿结成的全国性、专业性、学术性、非营利性社会组织。, copyright=0, guiderPublishedTime=Fri Nov 01 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>目前,非酒精性脂肪性肝病(NAFLD)已成为我国最常见的慢性肝病。本建议从以下5 个方面对NAFLD 的规范化诊断和治疗进行了修订:(1)诊治中心/ 专病门诊的组织架构及功能;(2)筛查和评估:包括筛查对象、初步评估、病因筛查、非酒精性脂肪性肝炎和进展性肝纤维化的无创诊断、肝活组织病理学检查以及代谢紊乱和心血管风险评估等;(3)临床处理包括生活方式(饮食运动减重)调整,合并糖脂代谢紊乱、高血压等特殊人群的处理以及脂肪性肝炎和肝纤维化的药物选择;(4)特殊人群的管理包括儿童、妊娠和哺乳期妇女、合并酒精性肝病、慢性HBV 和(或)HCV 感染以及合并自身免疫现象等;(5)监测与随访。本建议旨在优化NAFLD 患者的管理流程,指导临床医生制订更为合理的诊疗决策。</P> <P> </P>拓展指南:<strong>与<font color=red>脂肪肝</font>相关指南:</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=640e11c001622579" title="儿童非酒精性脂肪肝病诊断与治疗专家共识" target=_blank>儿童非酒精性脂肪肝病诊断与治疗专家共识</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=e140a1c001a6e0c8" title="2017 亚太工作组指南:非酒精性脂肪肝" target=_blank>2017 亚太工作组指南:非酒精性脂肪肝</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=409d31c0011969f1" title="ESPGHAN共识声明:伴或不伴非酒精性脂肪肝炎的严重肥胖儿童和青少年进行减肥干预的适应症及局限性(2015年)" target=_blank>ESPGHAN共识声明:伴或不伴非酒精性脂肪肝炎的严重肥胖儿童和青少年进行减肥干预的适应症及局限性(2015年)</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=841791c0011590c0" title="非酒精性脂肪肝肝活检评估共识" target=_blank>非酒精性脂肪肝肝活检评估共识</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=7f1ae1c0011a8e9a" title="2015 JSGE循证临床实践指南:非酒精性脂肪肝病/非酒精性脂肪肝炎" target=_blank>2015 JSGE循证临床实践指南:非酒精性脂肪肝病/非酒精性脂肪肝炎</a></li> 更多信息请点击:<a href="//m.capotfarm.com/guideline/list.do?q=%E8%84%82%E8%82%AA%E8%82%9D" target=_blank>有关脂肪肝更多指南</a></ul>, tagList=[TagDto(tagId=8700, tagName=脂肪性肝病), TagDto(tagId=83247, tagName=诊疗规范化)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=22, categoryName=肝病, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=9318, appHits=694, showAppHits=40, pcHits=5710, showPcHits=4063, likes=108, shares=62, comments=17, approvalStatus=1, publishedTime=Sat Nov 09 23:05:45 CST 2019, publishedTimeString=2019-11-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Nov 09 23:05:45 CST 2019, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 17:59:34 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=脂肪性肝病诊疗规范化的专家建议(2019 年修订版))])
脂肪性肝病诊疗规范化的专家建议(2019 年修订版)
下载请点击:
评论区 (16)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1212322, encodeId=8a691212322fd, content=NAFLD有可能合并的其他学科的疾病阐述的很细致, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab606579033, createdName=ms8000001408294061, createdTime=Mon Apr 18 22:33:52 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212319, encodeId=9d9c121231969, content=为脂肪肝的治疗指明了方向, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab606579033, createdName=ms8000001408294061, createdTime=Mon Apr 18 22:32:29 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967202, encodeId=0f5096e2024a, content=想学习,没积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a6a95153046, createdName=jolene, createdTime=Thu May 20 12:35:31 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959858, encodeId=5f799598589d, content=好多文章都想看,又没积分,咋办?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99e5481931, createdName=ms3000001603573773, createdTime=Fri Apr 23 18:52:44 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959857, encodeId=b49e95985ebf, content=怎样得到更多积分?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99e5481931, createdName=ms3000001603573773, createdTime=Fri Apr 23 18:52:24 CST 2021, time=2021-04-23, status=1, ipAttribution=)]
    2022-04-18 ms8000001408294061

    NAFLD有可能合并的其他学科的疾病阐述的很细致

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1212322, encodeId=8a691212322fd, content=NAFLD有可能合并的其他学科的疾病阐述的很细致, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab606579033, createdName=ms8000001408294061, createdTime=Mon Apr 18 22:33:52 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212319, encodeId=9d9c121231969, content=为脂肪肝的治疗指明了方向, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab606579033, createdName=ms8000001408294061, createdTime=Mon Apr 18 22:32:29 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967202, encodeId=0f5096e2024a, content=想学习,没积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a6a95153046, createdName=jolene, createdTime=Thu May 20 12:35:31 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959858, encodeId=5f799598589d, content=好多文章都想看,又没积分,咋办?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99e5481931, createdName=ms3000001603573773, createdTime=Fri Apr 23 18:52:44 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959857, encodeId=b49e95985ebf, content=怎样得到更多积分?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99e5481931, createdName=ms3000001603573773, createdTime=Fri Apr 23 18:52:24 CST 2021, time=2021-04-23, status=1, ipAttribution=)]
    2022-04-18 ms8000001408294061

    为脂肪肝的治疗指明了方向

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1212322, encodeId=8a691212322fd, content=NAFLD有可能合并的其他学科的疾病阐述的很细致, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab606579033, createdName=ms8000001408294061, createdTime=Mon Apr 18 22:33:52 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212319, encodeId=9d9c121231969, content=为脂肪肝的治疗指明了方向, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab606579033, createdName=ms8000001408294061, createdTime=Mon Apr 18 22:32:29 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967202, encodeId=0f5096e2024a, content=想学习,没积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a6a95153046, createdName=jolene, createdTime=Thu May 20 12:35:31 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959858, encodeId=5f799598589d, content=好多文章都想看,又没积分,咋办?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99e5481931, createdName=ms3000001603573773, createdTime=Fri Apr 23 18:52:44 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959857, encodeId=b49e95985ebf, content=怎样得到更多积分?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99e5481931, createdName=ms3000001603573773, createdTime=Fri Apr 23 18:52:24 CST 2021, time=2021-04-23, status=1, ipAttribution=)]
    2021-05-20 jolene

    想学习,没积分

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1212322, encodeId=8a691212322fd, content=NAFLD有可能合并的其他学科的疾病阐述的很细致, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab606579033, createdName=ms8000001408294061, createdTime=Mon Apr 18 22:33:52 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212319, encodeId=9d9c121231969, content=为脂肪肝的治疗指明了方向, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab606579033, createdName=ms8000001408294061, createdTime=Mon Apr 18 22:32:29 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967202, encodeId=0f5096e2024a, content=想学习,没积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a6a95153046, createdName=jolene, createdTime=Thu May 20 12:35:31 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959858, encodeId=5f799598589d, content=好多文章都想看,又没积分,咋办?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99e5481931, createdName=ms3000001603573773, createdTime=Fri Apr 23 18:52:44 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959857, encodeId=b49e95985ebf, content=怎样得到更多积分?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99e5481931, createdName=ms3000001603573773, createdTime=Fri Apr 23 18:52:24 CST 2021, time=2021-04-23, status=1, ipAttribution=)]
    2021-04-23 ms3000001603573773

    好多文章都想看,又没积分,咋办?

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1212322, encodeId=8a691212322fd, content=NAFLD有可能合并的其他学科的疾病阐述的很细致, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab606579033, createdName=ms8000001408294061, createdTime=Mon Apr 18 22:33:52 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212319, encodeId=9d9c121231969, content=为脂肪肝的治疗指明了方向, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab606579033, createdName=ms8000001408294061, createdTime=Mon Apr 18 22:32:29 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967202, encodeId=0f5096e2024a, content=想学习,没积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a6a95153046, createdName=jolene, createdTime=Thu May 20 12:35:31 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959858, encodeId=5f799598589d, content=好多文章都想看,又没积分,咋办?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99e5481931, createdName=ms3000001603573773, createdTime=Fri Apr 23 18:52:44 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959857, encodeId=b49e95985ebf, content=怎样得到更多积分?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99e5481931, createdName=ms3000001603573773, createdTime=Fri Apr 23 18:52:24 CST 2021, time=2021-04-23, status=1, ipAttribution=)]
    2021-04-23 ms3000001603573773

    怎样得到更多积分?

    0

Baidu
map
Baidu
map
Baidu
map